THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET SIZE IS EXPECTED TO REACH USD 266.80 BILLION BY 2026, GROWING AT A CAGR OF 6.22% DURING THE PERIOD 2021-2026

Active Pharmaceutical Ingredients Market Size, Share, & Trends Analysis Report By

Application: Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others
Molecule Type: Small and Large
Type of manufacturers: Captive and Merchant
Type of drugs: Prescription and Over the counter
Synthesis Type: Synthetic and Biotech
Geography: North America, Europe, APAC, Latin America, and the Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026.

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

284 Pages

icon-table

133 Tables

icon-chart

89 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

25 Companies

icon-market

6 Market Segment

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 266.80 BILLION (2026)
CAGR 6.22% (2021-2026)
BASE YEAR 2020
FORECAST YEAR 2021-2026
MARKET SEGMENTS Application (Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others), Molecule Type (Small and Large), Type of manufacturers (Captive and Merchant), Type of drugs (Prescription and Over the counter), and Synthesis Type (Synthetic and Biotech)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED US, Canada, United Kingdom, Germany, France, Italy, Spain, Russia, China, India, Indonesia, Japan, Singapore, Brazil, Mexico, Saudi Arabia, South Africa, and UAE

ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET OUTLOOK

The global active pharmaceutical ingredients (API) market size was valued at USD 185.72 billion in 2020 and is expected to reach USD 266.80 billion by 2026, growing at a compound annual growth rate (CAGR) of 6.22%. 

Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery systems and the evolution of personalized medicines, will further emphasize the growing demand for advanced Aher. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.

SNIPPETS

  • Based on Molecule type, the small molecule is the largest segment and is projected to grow higher than the overall active pharmaceutical ingredient market.
  • Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth in the market.
  • The oncology API market size is the largest in the application segment. The expected growth is because of large-scale development resulting from the availability of abundant prospects available in the global forecast period of 2020-2026.

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTS

  • The increasing awareness of various APIs' improved efficacy on targeted cancerous cells is also propelling their demand for oncology drugs. Oncology API will register a handsome growth until 2026.
  • The rise in internet penetration enables various online platforms to collaborate with pharmaceutical companies to deliver drugs such as analgesics at the doorstep of consumers. 
  • The captive segment held the largest market share due to major key companies' intensive capitalization in developing high-end manufacturing facilities.
  • Companies in the biotech API manufacturing services market are acquiring agency perspectives from the Center for drug evaluation and research (CDER) to gain a competitive edge over other players. 

GEOGRAPHICAL ANALYSIS

The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient market. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period. 

The European market grew with the increase in technological advancements to enhance the capabilities and boost the manufacturing skills of the players. The active pharmaceutical ingredients market in Europe is expected to reach almost USD 50 billion in the coming years.

VENDORS ANALYSIS

The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.

The active pharmaceutical ingredients market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

  • Application
    • Oncology
    • Cardiovascular Disease
    • Anti-infectives
    • Central Nervous System
    • Respiratory diseases
    • Diabetes
    • Pain management
    • Others
  • Molecule Type
    • Small
    • Large
  • Type of manufacturers
    • Captive
    • Merchant
  • Type of drugs
    • Prescription
    • Over the counter
  • Synthesis Type
    • Synthetic
    • Biotech
  • Geography
  • North America
    • US
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • India
    • Indonesia
    • Japan
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Frequently Asked Questions

How big is the active pharmaceutical ingredient market?

The active pharmaceutical ingredients (API) market is expected to reach USD 266.80 billion by 2026.

What are the different applications in the global active pharmaceutical ingredient market?

Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others are the different applications in the global active pharmaceutical ingredient market.

Who are the key players in the active pharmaceutical ingredient (API) market?

Pfizer Inc., Cipla Inc., Novartis AG, Mylan N.V., and Sun Pharmaceuticals Industries Ltd. are the key players in the active pharmaceutical ingredient (API) market.

What are the latest trends in the active pharmaceutical ingredient market?

Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth.

What are the key driving factors in the global API market?

The invention of new generation API and increase in demand for generic drugs.

Download Free Sample

The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%.

The following factors are likely to contribute to the growth of the active pharmaceutical ingredients market during the forecast period:

  • The invention of new generation API
  • Increase in Demand for Generic Drugs
  • High Adoption of Mergers and Acquisitions
  • Impact of API Outsourcing

Base Year: 2020 

Forecast Year: 2021- 2026

The study considers a detailed scenario of the present active pharmaceutical ingredients market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Key Vendors

  • Pfizer Inc.
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Cipla Inc.
  • Novartis AG
  • Mylan N.V.
  • Sun Pharmaceuticals Industries Ltd.

Other Prominent Vendors

  • Albemarle Corporation
    • Business Overview
    • Key Highlights
  • AbbVie Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Bristol-Myers Squibb
  • Aurobindo Pharma limited
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • BASF SE
  • Lupin
  • Shenzhen Hepalink Pharmaceutical Group Ltd.
  • Abbott
  • Biocon
  • Amgen Inc.
  • GlaxoSmithKline Plc
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Viatris Inc.,
  • Glenmark Pharmaceuticals

Market Segmentation by Application

  • Oncology
  • Cardiovascular Disease
  • Anti-infectives
  • Central Nervous System
  • Respiratory diseases
  • Diabetes
  • Pain management
  • Others

Market Segmentation by Molecule Type

  • Small
  • Large

Market Segmentation by Type of manufacturers

  • Captive
  • Merchant

Market Segmentation by Type of drugs

  • Prescription
  • Over the counter

Market Segmentation by Synthesis Type

  • Synthetic
  • Biotech

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • India
    • Indonesia
    • Japan
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.01.01 Inclusions

4.01.02 Exclusions

4.01.03 Market Estimation Caveats

4.2 Base Year

4.3 Scope Of The Study

4.03.01 Market Segmentation By Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

7.2 Impact Of Covid-19

8 Growth Opportunity By Segment

8.1 By Application

8.2 By Molecule

8.3 By Manufacturers

8.4 By Synthesis

8.5 By Drug Type

8.6 By Geography

9 Market Opportunities &Trends

9.1 Growing Demand For Generic Drugs

9.2 Increasing Digitalization In Healthcare

9.3 Mergers & Acquisitions In Pharmaceutical Industry

10 Market Growth Enablers

10.1 Invention Of New Generation APIs

10.2 Growth In API Outsourcing Operations

11 Market Growth Restraints

11.1 Stringent Government Regulations

11.2 Analytical Challenges In Testing Processes

12 Market Landscape

12.1 Market Overview

12.2 Market Size & Forecast

12.3 Five Forces Analysis

12.03.01 Threat Of New Entrants

12.03.02 Bargaining Power Of Suppliers

12.03.03 Bargaining Power Of Buyers

12.03.04 Threat Of Substitutes

12.03.05 Competitive Rivalry

13 Application

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Oncology

13.03.01 Market Overview

13.03.02 Market Size & Forecast

13.03.03 Market By Geography

13.4 Diabetes

13.04.01 Market Overview

13.04.02 Market Size & Forecast

13.04.03 Market By Geography

13.5 Cardiovascular

13.05.01 Market Overview

13.05.02 Market Size & Forecast

13.05.03 Market By Geography

13.6 Respiratory Diseases

13.06.01 Market Overview

13.06.02 Market Size & Forecast

13.06.03 Market By Geography

13.7 Pain Management

13.07.01 Market Overview

13.07.02 Market Size & Forecast

13.07.03 Market By Geography

13.8 Anti-Infectives

13.08.01 Market Overview

13.08.02 Market Size & Forecast

13.08.03 Market By Geography

13.9 Central Nervous System

13.09.01 Market Overview

13.09.02 Market Size & Forecast

13.09.03 Market By Geography

14 Molecule Size

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Small Molecule

14.03.01 Market Overview

14.03.02 Market Size & Forecast

14.03.03 Market By Geography

14.4 Large Molecule

14.04.01 Market Overview

14.04.02 Market Size & Forecast

14.04.03 Market By Geography

15 Type Of Manufacturers

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Captive Manufacturing

15.03.01 Market Overview

15.03.02 Market Size & Forecast

15.03.03 Market By Geography

15.4 Merchant Manufacturing

15.04.01 Market Overview

15.04.02 Market Size & Forecast

15.04.03 Market By Geography

16 Types Of Drugs

16.1 Market Snapshot & Growth Engine

16.2 Market Overview

16.3 Over-The-Counter Drugs

16.03.01 Market Overview

16.03.02 Market Size & Forecast

16.03.03 Market By Geography

16.4 Prescription Drugs

16.04.01 Market Overview

16.04.02 Market Size & Forecast

16.04.03 Market By Geography

17 Synthesis Type

17.1 Market Snapshot & Growth Engine

17.2 Market Overview

17.3 Synthetic API

17.03.01 Market Overview

17.03.02 Market Size & Forecast

17.03.03 Market By Geography

17.4 Biotech API

17.04.01 Market Overview

17.04.02 Market Size & Forecast

17.04.03 Market By Geography

18 Geography

18.1 Market Snapshot & Growth Engine

18.2 Geographic Overview

19 North America

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Application

19.03.01 Market Size & Forecast

19.4 Molecule

19.04.01 Market Size & Forecast

19.5 Manufacturers

19.05.01 Market Size & Forecast

19.6 Synthesis Type

19.06.01 Market Size & Forecast

19.7 Type Of Drugs

19.07.01 Market Size & Forecast

19.8 Key Countries

19.08.01 Us: Market Size & Forecast

19.08.02 Canada: Market Size & Forecast

20 Europe

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Application

20.03.01 Market Size & Forecast

20.4 Molecule

20.04.01 Market Size & Forecast

20.5 Manufacturers

20.05.01 Market Size & Forecast

20.6 Synthesis Type

20.06.01 Market Size & Forecast

20.7 Type Of Drugs

20.07.01 Market Size & Forecast

20.8 Key Countries

20.08.01 UK: Market Size & Forecast

20.08.02 Germany: Market Size & Forecast

20.08.03 France: Market Size & Forecast

20.08.04 Italy: Market Size & Forecast

20.08.05 Spain: Market Size & Forecast

20.08.06 Russia: Market Size & Forecast

21 APAC

21.1 Market Overview

21.2 Market Size & Forecast

21.3 Application

21.03.01 Market Size & Forecast

21.4 Molecule

21.04.01 Market Size & Forecast

21.5 Manufacturers

21.05.01 Market Size & Forecast

21.6 Synthesis Type

21.06.01 Market Size & Forecast

21.7 Type Of Drugs

21.07.01 Market Size & Forecast

21.8 Key Countries

21.08.01 China: Market Size & Forecast

21.08.02 India: Market Size & Forecast

21.08.03 Indonesia: Market Size & Forecast

21.08.04 Japan: Market Size & Forecast

21.08.05 Singapore: Market Size & Forecast

22 Latin America

22.1 Market Overview

22.2 Market Size & Forecast

22.3 Application

22.03.01 Market Size & Forecast

22.4 Molecule

22.04.01 Market Size & Forecast

22.5 Manufacturers

22.05.01 Market Size & Forecast

22.6 Synthesis Type

22.06.01 Market Size & Forecast

22.7 Type Of Drugs

22.07.01 Market Size & Forecast

22.8 Key Countries

22.08.01 Brazil: Market Size & Forecast

22.08.02 Mexico: Market Size & Forecast

23 Middle East & Africa

23.1 Market Overview

23.2 Market Size & Forecast

23.3 Application

23.03.01 Market Size & Forecast

23.4 Molecule

23.04.01 Market Size & Forecast

23.5 Manufacturers

23.05.01 Market Size & Forecast

23.6 Synthesis Type

23.06.01 Market Size & Forecast

23.7 Type Of Drugs

23.07.01 Market Size & Forecast

23.8 Key Countries

23.08.01 Saudi Arabia: Market Size & Forecast

23.08.02 South Africa: Market Size & Forecast

23.08.03 UAE: Market Size & Forecast

24 Competitive Landscape

24.1 Competition Overview

25 Key Company Profiles

25.1 PFIZER INC.

25.01.01 Business Overview

25.01.02 Pfizer Inc. in Global Active Pharmaceutical Ingredients Market

25.01.03 Product Offerings

25.01.04 Key Strategies

25.01.05 Key Strengths

25.01.06 Key Opportunities

25.2 CIPLA INC.

25.02.01 Business Overview

25.02.02 Cipla Inc. in Global Active Pharmaceutical Ingredients Market

25.02.03 Product Offerings

25.02.04 Key Strategies

25.02.05 Key Strengths

25.02.06 Key Opportunities

25.3 NOVARTIS AG

25.03.01 Business Overview

25.03.02 Novartis AG in Active pharmaceutical ingredients Market

25.03.03 Product Offerings

25.03.04 Key Strategies

25.03.05 Key Strengths

25.03.06 Key Opportunities

25.4 MYLAN N.V.

25.04.01 Business Overview

25.04.02 Mylan N.V. in Global Active Pharmaceutical Ingredients Market

25.04.03 Product Offerings

25.04.04 Key Strategies

25.04.05 Key Strengths

25.04.06 Key Opportunities

25.5 SUN PHARMACEUTICAL INDUSTRIES LTD.

25.05.01 Business Overview

25.05.02 Sun Pharmaceutical Industries Ltd. in Global Active Pharmaceutical Ingredients Market

25.05.03 Product Offerings

25.05.04 Key Strategies

25.05.05 Key Strengths

25.05.06 Key Opportunities

26 Other Prominent Vendors

26.1 ALBEMARLE CORPORATION

26.01.01 Business Overview

26.01.02 Key Highlights

26.2 ABBVIE INC.

26.02.01 Business Overview

26.02.02 Key Highlights

26.3 DR. REDDY’S LABORATORIES LTD.

26.03.01 Business Overview

26.03.02 Key Highlights

26.4 ELI LILLY AND COMPANY

26.04.01 Business Overview

26.04.02 Key Highlights

26.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.

26.05.01 Business Overview

26.05.02 Key Highlights

26.6 BRISTOL-MYERS SQUIBB

26.06.01 Business Overview

26.06.02 Key Highlights

26.7 AUROBINDO PHARMA

26.07.01 Business Overview

26.07.02 Key Highlights

26.8 SANOFI

26.08.01 Business Overview

26.08.02 Key Highlights

26.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

26.09.01 Business Overview

26.09.02 Key Highlights

26.10 BASF SE

26.10.01 Business Overview

26.10.02 Key Highlights

26.11 LUPIN

26.11.01 Business Overview

26.11.02 Key Highlights

26.12 SHENZHEN HEPALINK PHARMACEUTICAL GROUP

26.12.01 Business Overview

26.12.02 Key Highlights

26.13 ABBOTT

26.13.01 Business Overview

26.13.02 Key Highlights

26.14 BIOCON

26.14.01 Business Overview

26.14.02 Key Highlights

26.15 AMGEN INC.

26.15.01 Business Overview

26.15.02 Key Highlights

26.16 GLAXOSMITHKLINE PLC.

26.16.01 Business Overview

26.16.02 Key Highlights

26.17 F. HOFFMANN-LA ROCHE LTD.

26.17.01 Business Overview

26.17.02 Key Highlights

26.18 MERCK KGAA

26.18.01 Business Overview

26.18.02 Key Highlights

26.19 VIATRIS INC.

26.19.01 Business Overview

26.19.02 Key Highlights

26.20 GLENMARK PHARMACEUTICALS

26.20.01 Business Overview

26.20.02 Key Highlights

27 Report Summary

27.1 Key Takeaways

27.2 Strategic Recommendations

28 Quantitative Summary

28.1 Application

28.01.01 Oncology

28.01.02 Cardiovascular Disease

28.01.03 Anti-infectives

28.01.04 CNS

28.01.05 Pain Management

28.01.06 Diabetes

28.01.07 Respiratory Disease

28.2 MOLECULE TYPE

28.02.01 Small Molecule

28.02.02 Large Molecule API

28.3 SYNTHESIS TYPE

28.03.01 Synthetic API

28.03.02 Biotech API

28.4 MANUFACTURERS

28.04.01 Captive Manufacturing

28.04.02 Merchant Manufacturing

28.5 DRUG TYPE

28.05.01 Over-the-counter drugs

28.05.02 Prescription Drugs API

28.6 GEOGRAPHY

28.06.01 North America

28.06.02 Europe

28.06.03 APAC

28.06.04 Latin America

28.06.05 Middle East and Africa

29 Appendix

29.1 Abbreviations

LIST OF EXHIBITS            

Exhibit 1             Segmentation of Global Active Pharmaceutical Ingredients Market

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Market Size of Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 4             Biotech API Manufacturing Process

Exhibit 5             Synthetic API Manufacturing Process

Exhibit 6             Growth Drivers in Global Active Pharmaceutical Ingredients Market

Exhibit 7             Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Exhibit 8             Global Active Pharmaceutical Ingredients Market by Molecule ($ billion)

Exhibit 9             Global Active Pharmaceutical Ingredients Market by Manufacturing ($ billion)

Exhibit 10           Global Active Pharmaceutical Ingredients Market by Synthesis ($ billion)

Exhibit 11           Global Active Pharmaceutical Ingredients Market by Drug Type ($ billion)

Exhibit 12           Global Active Pharmaceutical Ingredients Market by Geography ($ billion)

Exhibit 13           Impact of Growing Demand for Generic Drugs

Exhibit 14           Definition of Generic Medicine

Exhibit 15           Types of Generics

Exhibit 16           Impact of Increasing Digitalization in Healthcare

Exhibit 17           Impact of Mergers and Acquisitions in Pharmaceutical Industry

Exhibit 18           Strategies for Mergers & Acquisitions

Exhibit 19           Impact of Invention of New Generation APIs

Exhibit 20           Challenges with Peptide APIs

Exhibit 21           Impact of Growth in API Outsourcing Operations

Exhibit 22           Advantages of Outsourcing

Exhibit 23           Impact of Stringent Government Regulations

Exhibit 24           Impact of Analytical Challenges in Testing Processes

Exhibit 25           Current Trends in Global APIs Market

Exhibit 26           Global Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 27           Five Forces Analysis 2020

Exhibit 28           Incremental Growth by Application 2020 & 2026

Exhibit 29           Global Oncology Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 30           Global Diabetes Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 31           Global Cardiovascular Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 32           Global Respiratory Diseases Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 33           Global Pain Management Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 34           Global Anti-infective Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 35           Global CNS Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 36           Incremental Growth by Molecule 2020 & 2026

Exhibit 37           Global Active Pharmaceutical Ingredients Market by Molecule Size (% share)

Exhibit 38           Global Small Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 39           Global Large Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 40           Incremental Growth by Manufacturing 2020 & 2026

Exhibit 41           Advantages of Merchant Manufacturing

Exhibit 42           Advantages of Captive Manufacturing

Exhibit 43           Global Captive Manufacturing Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 44           Challenges in Outsourcing

Exhibit 45           Advantages of Contract Manufacturing

Exhibit 46           Global Merchant Manufacturing APIs Market 2020–2026 ($ billion)

Exhibit 47           Incremental Growth by Drugs 2020 & 2026

Exhibit 48           Key Differences

Exhibit 49           Global OTC Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 50           Global Prescription Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 51           Incremental Growth by Synthesis 2020 & 2026

Exhibit 52           Global Synthetic Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 53           Global Biotech Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 54           Incremental Growth by Geography 2020 & 2026

Exhibit 55           Global Active Pharmaceutical Ingredients Market by Region (CAGR %)

Exhibit 56           North America Active Pharmaceutical Ingredients Market 2020–2026

Exhibit 57           North America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 58           Incremental Growth in North America 2020 & 2026

Exhibit 59           Active Pharmaceutical Ingredients Market in US 2020–2026 ($ billion)

Exhibit 60           Active Pharmaceutical Ingredients Market in Canada 2020–2026 ($ billion)

Exhibit 61           Factors Fueling Success of CMOs in Europe

Exhibit 62           Europe Global Active Pharmaceutical Ingredients Market

Exhibit 63           Europe Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 64           Incremental Growth in Europe 2020 & 2026

Exhibit 65           Active Pharmaceutical Ingredients Market in UK 2020–2026 ($ billion)

Exhibit 66           Active Pharmaceutical Ingredients Market in Germany 2020–2026 ($ billion)

Exhibit 67           Active Pharmaceutical Ingredients Market in France 2020–2026 ($ billion)

Exhibit 68           Active Pharmaceutical Ingredients Market in Italy 2020–2026 ($ billion)

Exhibit 69           Active Pharmaceutical Ingredients Market in Spain 2020–2026 ($ billion)

Exhibit 70           Active Pharmaceutical Ingredients Market in Russia 2020–2026 ($ billion)

Exhibit 71           APAC Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 72           Incremental Growth in APAC 2020 & 2026

Exhibit 73           Active Pharmaceutical Ingredients Market in China 2020–2026 ($ billion)

Exhibit 74           Active Pharmaceutical Ingredients Market in India 2020–2026 ($ billion)

Exhibit 75           Challenges Faced by Indian API Industry

Exhibit 76           Active Pharmaceutical Ingredients Market in Indonesia 2020–2026 ($ billion)

Exhibit 77           Active Pharmaceutical Ingredients Market in Japan 2020–2026 ($ billion)

Exhibit 78           Active Pharmaceutical Ingredients Market in Singapore 2020–2026 ($ billion)

Exhibit 79           Latin America Global Active Pharmaceutical Ingredients Market

Exhibit 80           Latin America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 81           Incremental Growth in Latin America 2020 & 2026

Exhibit 82           Active Pharmaceutical Ingredients Market in Brazil 2020–2026 ($ billion)

Exhibit 83           Active Pharmaceutical Ingredients Market in Mexico 2020–2026 ($ billion)

Exhibit 84           Middle East & Africa Active Pharmaceutical Ingredients Market

Exhibit 85           Middle East & Africa Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)

Exhibit 86           Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 87           Active Pharmaceutical Ingredients Market in Saudi Arabia 2020–2026 ($ billion)

Exhibit 88           Active Pharmaceutical Ingredients Market in South Africa 2020–2026 ($ billion)

Exhibit 89           Active Pharmaceutical Ingredients Market in UAE 2020–2026 ($ billion)

             

LIST OF TABLES 

Table 1                Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 4               Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 5               Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 6               Global Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 7               Global Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 8               Global Pharmaceutical Ingredients Market by Region 2020–2026 ($ billion)

Table 9               Global Oncology APIs Market by Geography 2020–2026 ($ billion)

Table 10              Global Diabetes APIs Market by Geography 2020–2026 ($ billion)

Table 11              Global Cardiovascular APIs Market by Geography 2020–2026 ($ billion)

Table 12              Global Respiratory Diseases APIs Market by Geography 2020–2026 ($ billion)

Table 13              Global Pain Management APIs Market by Geography 2020–2026 ($ billion)

Table 14              Global Anti-infective APIs Market by Geography 2020–2026 ($ billion)

Table 15              Global Central Nervous System APIs Market by Geography 2020–2026 ($ billion)

Table 16              Global Small Molecule APIs Market by Geography 2020–2026 ($ billion)

Table 17              Global Large Molecule APIs Market by Geography 2020–2026 ($ billion)

Table 18              Global Captive Manufacturing APIs Market by Geography 2020–2026 ($ billion)

Table 19              Global Merchant Manufacturing APIs Market by Geography 2020–2026 ($ billion)

Table 20              Global Over-the-counter APIs Market by Geography 2020–2026 ($ billion)

Table 21              Global Prescription Drug APIs Market by Geography 2020–2026 ($ billion)

Table 22              Global Synthetic APIs Market by Geography 2020–2026 ($ billion)

Table 23              Global Biotech APIs Market by Geography 2020–2026 ($ billion)

Table 24              North America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 25              North America Active Pharmaceutical Ingredients by Molecule 2020–2026 ($ billion)

Table 26              North America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 27              North America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 28              North America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 29              Europe Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 30              Europe Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 31              Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020–2026 ($ billion)

Table 32              Europe Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 33              Europe Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 34              APAC Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 35              APAC Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 36              APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 37              APAC Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 38              APAC Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 39              Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 40              Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 41              Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 42              Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026  ($ billion)

Table 43              Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 44              MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 45              MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 46              MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 47              MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 48              MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 49              Pfizer Inc.: Major Product Offerings

Table 50              Cipla Inc.: Major Product Offerings

Table 51              Novartis AG: Major Product Offerings

Table 52              Mylan N.V.: Major Product Offerings

Table 53              Sun Pharmaceutical Industries Ltd.: Major Product Offerings

Table 54              Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 55              Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 56              Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 57              Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 58              Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 59              Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 60              Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 61              Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 62              Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 63              Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 64              Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 65              Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 66              Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 67              Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 68              Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 69              Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 70              Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)

Table 71              Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)

Table 72              Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 73              Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 74              Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 75              Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 76              Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 77              Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 78              Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 79              Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 80              Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 81              Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 82              Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)

Table 83              Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)

Table 84              North America Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)

Table 85              North America Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)

Table 86              North America Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)

Table 87              North America Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)

Table 88              North America Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 ($ billion)

Table 89              North America Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 (% share)

Table 90              North America Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)

Table 91              North America Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)

Table 92              North America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)

Table 93              North America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 (% share)

Table 94              Europe Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)

Table 95              Europe Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)

Table 96              Europe Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)

Table 97              Europe Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)

Table 98              Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 ($ billion)

Table 99              Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 (% share)

Table 100           Europe Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)

Table 101           Europe Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)

Table 102           Europe Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)

Table 103           Europe Active Pharmaceutical Ingredients by Drugs 2020−2026 (% share)

Table 104           APAC Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)

Table 105           APAC Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)

Table 106           APAC Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)

Table 107           APAC Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)

Table 108           APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020−2026 ($ billion)

Table 109           APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020−2026 (% share)

Table 110           APAC Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)

Table 111           APAC Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)

Table 112           APAC Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)

Table 113           APAC Active Pharmaceutical Ingredients Market by Drugs 2020−2026 (% share)

Table 114           Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 115           Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)

Table 116           Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 117           Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)

Table 118           Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 119           Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)

Table 120           Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 121           Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)

Table 122           Latin America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)

Table 123           Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)

Table 124           MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)

Table 125           MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)

Table 126           MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)

Table 127           MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)

Table 128           MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)

Table 129           MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)

Table 130           MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)

Table 131           MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)

Table 132           MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)

Table 133           MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date